Rebecca Mehrwerth
Plus aucun poste en cours
Profil
Rebecca Mehrwerth worked as the SVP & Head-Commercial at Epizyme, Inc.
Anciens postes connus de Rebecca Mehrwerth
| Sociétés | Poste | Fin |
|---|---|---|
| EPIZYME, INC. | Corporate Officer/Principal | 01/01/2023 |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
